Search Results - "de Oliveira, Andressa P"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
  2. 2

    Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells by Azevedo, Liviane D., Leite, Debora I., Oliveira, Andressa P., Junior, Floriano P. S., Dantas, Rafael F., Bastos, Monica M., Boechat, Nubia, Pimentel, Luiz C. F.

    Published in Archiv der Pharmazie (Weinheim) (01-08-2024)
    “…Imatinib mesylate was the first representative BCR‐ABL1 tyrosine kinase inhibitor (TKI) class for the treatment of chronic myeloid leukemia. Despite the…”
    Get full text
    Journal Article